Hidden homeowner costs climb to nearly $16,000 a year, Eli Lilly approaches trillion-dollar status amid weight-loss drug ...
Pharmaceutical giant Merck announced the cancellation of a planned $1.3 billion research center in London and the termination ...
In the last five years, LLY has drawn 23 outlier inflow signals and is up 387.5%. The blue bars below show when LLY was a top ...
Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...
These drugs promise faster results with fewer side effects, and in some cases, reversal or slows the disease progression.
Tribune Content Agency on MSN
Medicare to cover obesity drugs under Trump deal for as little as $50
The White House recently announced a landmark deal with pharmaceutical companies Eli Lilly and Nordisk that will impact ...
Novo Nordisk goes "on the offensive" following Trump deal that also included rival Eli Lilly, putting an exclamation point on rapidly declining GLP-1 drug prices. Experts say the unusual situation ...
Operated by the federal government, TrumpRx aims to reduce the amount that Americans — including Medicaid patients — pay for ...
Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal ...
The trillion-dollar club has become crowded with mostly tech names riding the AI boom. Eli Lilly might soon join them for a ...
Eli Lilly shares rose again Tuesday, their sixth increase in the past seven sessions. The drugmaker's market cap also closed ...
The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback